1. Beta agonist-related tremorogenic effects

   Newsletter Article 27 January 2013 Pages: 1 - 1

2. Careful consideration of herbal medicines required

   Newsletter Article 27 January 2013 Pages: 1 - 1

3. Estazolam-related adverse effects: a meta-analysis

   Newsletter Article 27 January 2013 Pages: 2 - 2

4. Renal effects of NSAIDs

   Newsletter Article 27 January 2013 Pages: 2 - 3

5. Cefaclor and serum sickness - no small matter?

   Newsletter Article 27 January 2013 Pages: 3 - 4

6. The adverse effects of ACE inhibitors

   Newsletter Article 27 January 2013 Pages: 4 - 5

7. Allopurinol

   Newsletter Article 27 January 2013 Pages: 5 - 5

8. Aminoglycosides

   Newsletter Article 27 January 2013 Pages: 5 - 6

9. Anabolic steroid dependence

   Newsletter Article 27 January 2013 Pages: 6 - 6

10. Antineoplastics

    Newsletter Article 27 January 2013 Pages: 6 - 6

11. Aspirin overdose

    Newsletter Article 27 January 2013 Pages: 6 - 6

12. Azathioprine

    Newsletter Article 27 January 2013 Pages: 6 - 6

13. Benzocaine

    Newsletter Article 27 January 2013 Pages: 6 - 6

14. Carbidopa + levodopa withdrawal

    Newsletter Article 27 January 2013 Pages: 6 - 6

15. Chloroquine poisoning

    Newsletter Article 27 January 2013 Pages: 6 - 7

16. Cisplatin

    Newsletter Article 27 January 2013 Pages: 7 - 7

17. Clonidine poisoning

    Newsletter Article 27 January 2013 Pages: 7 - 7

18. Cocaine

    Newsletter Article 27 January 2013 Pages: 7 - 7

19. Cyclosporin

    Newsletter Article 27 January 2013 Pages: 7 - 7

20. Digoxin overdose

    Newsletter Article 27 January 2013 Pages: 7 - 8

21. Doxorubicin

    Newsletter Article 27 January 2013 Pages: 8 - 8

22. Etoposide

    Newsletter Article 27 January 2013 Pages: 8 - 8

23. Fenoprofen overdose

    Newsletter Article 27 January 2013 Pages: 8 - 8

24. Fenoterol

    Newsletter Article 27 January 2013 Pages: 8 - 8

25. Flecainide

    Newsletter Article 27 January 2013 Pages: 8 - 8

26. Floxuridine

    Newsletter Article 27 January 2013 Pages: 9 - 9

27. Flurbiprofen

    Newsletter Article 27 January 2013 Pages: 9 - 9

28. Flutamide

    Newsletter Article 27 January 2013 Pages: 10 - 10

29. Ibuprofen

    Newsletter Article 27 January 2013 Pages: 10 - 10

30. Ibuprofen/piroxicam/sulindac

    Newsletter Article 27 January 2013 Pages: 10 - 10

31. Ifosfamide

    Newsletter Article 27 January 2013 Pages: 10 - 11

32. Immunoglobulin

    Newsletter Article 27 January 2013 Pages: 11 - 11

33. Isopropamide see Trazodone interaction

    Newsletter Article 27 January 2013 Pages: 11 - 11

34. Levodopa see Carbidopa + levodopa withdrawal

    Newsletter Article 27 January 2013 Pages: 11 - 11

35. Lithium

    Newsletter Article 27 January 2013 Pages: 11 - 11

36. Mefloquine

    Newsletter Article 27 January 2013 Pages: 11 - 11

37. Metronidazole

    Newsletter Article 27 January 2013 Pages: 11 - 11

38. NSAIDs

    Newsletter Article 27 January 2013 Pages: 11 - 11

39. Piroxicam

    Newsletter Article 27 January 2013 Pages: 11 - 11

40. Piroxicam see Ibuprofen/piroxicam/sulindac

    Newsletter Article 27 January 2013 Pages: 11 - 11

41. Procainamide/tocainide/encainide

    Newsletter Article 27 January 2013 Pages: 11 - 11

42. Propafenone

    Newsletter Article 27 January 2013 Pages: 12 - 12

43. Ranitidine

    Newsletter Article 27 January 2013 Pages: 12 - 12

44. Sulfamethoxypyridazine

    Newsletter Article 27 January 2013 Pages: 12 - 12

45. Sulindac see Ibuprofen/piroxicam/sulindac

    Newsletter Article 27 January 2013 Pages: 12 - 12

46. Tobramycin

    Newsletter Article 27 January 2013 Pages: 12 - 12

47. Trazodone interaction

    Newsletter Article 27 January 2013 Pages: 12 - 12

48. Trihexyphenidyl withdrawal

    Newsletter Article 27 January 2013 Pages: 12 - 12

49. Vecuronium bromide

    Newsletter Article 27 January 2013 Pages: 12 - 12

50. Vigabatrin

    Newsletter Article 27 January 2013 Pages: 12 - 12